Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Ccdc92 | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CCDC92 mRNA] | CTD | PMID:31150632 | Ccdc92 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Ccdc92 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of CCDC92 mRNA | CTD | PMID:22206623 | Ccdc92 | Rat | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of CCDC92 mRNA | CTD | PMID:30723492 | Ccdc92 | Rat | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CCDC92 mRNA | CTD | PMID:32145629 | Ccdc92 | Rat | 2,3',4,4',5-Pentachlorobiphenyl | decreases expression | ISO | Ccdc92 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | Ccdc92 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ccdc92 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CCDC92 mRNA | CTD | PMID:21570461 and PMID:24680724 | Ccdc92 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Ccdc92 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CCDC92 mRNA | CTD | PMID:27913140 | Ccdc92 | Rat | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of CCDC92 mRNA | CTD | PMID:21346803 | Ccdc92 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CCDC92 mRNA | CTD | PMID:36041667 | Ccdc92 | Rat | 4-amino-2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 4-amino-2 and 6-dinitrotoluene affects the expression of CCDC92 mRNA | CTD | PMID:21346803 | Ccdc92 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of CCDC92 mRNA | CTD | PMID:24780913 | Ccdc92 | Rat | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of CCDC92 mRNA | CTD | PMID:23630614 and PMID:25378103 | Ccdc92 | Rat | all-trans-retinoic acid | decreases expression | ISO | CCDC92 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of CCDC92 mRNA | CTD | PMID:33167477 | Ccdc92 | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CCDC92 mRNA | CTD | PMID:35163327 | Ccdc92 | Rat | arsenous acid | multiple interactions | ISO | CCDC92 (Homo sapiens) | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CCDC92 protein] | CTD | PMID:26598702 | Ccdc92 | Rat | atrazine | decreases expression | ISO | CCDC92 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of CCDC92 mRNA | CTD | PMID:22378314 | Ccdc92 | Rat | azoxystrobin | decreases expression | ISO | CCDC92 (Homo sapiens) | 6480464 | azoxystrobin results in decreased expression of CCDC92 mRNA | CTD | PMID:33512557 | Ccdc92 | Rat | benzo[a]pyrene | increases expression | ISO | CCDC92 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of CCDC92 mRNA | CTD | PMID:20106945 and PMID:21632981 | Ccdc92 | Rat | benzo[a]pyrene | affects methylation | ISO | CCDC92 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of CCDC92 5' UTR | CTD | PMID:27901495 | Ccdc92 | Rat | benzo[e]pyrene | decreases methylation | ISO | CCDC92 (Homo sapiens) | 6480464 | benzo(e)pyrene results in decreased methylation of CCDC92 intron | CTD | PMID:30157460 | Ccdc92 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of CCDC92 mRNA | CTD | PMID:25181051 | Ccdc92 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CCDC92 mRNA | CTD | PMID:36041667 | Ccdc92 | Rat | bisphenol A | increases expression | ISO | Ccdc92 (Mus musculus) | 6480464 | bisphenol A results in increased expression of CCDC92 mRNA | CTD | PMID:32156529 | Ccdc92 | Rat | bisphenol A | increases methylation | ISO | CCDC92 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of CCDC92 gene | CTD | PMID:31601247 | Ccdc92 | Rat | bisphenol A | decreases methylation | ISO | Ccdc92 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of CCDC92 promoter | CTD | PMID:27312807 | Ccdc92 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CCDC92 mRNA | CTD | PMID:30816183 | Ccdc92 | Rat | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CCDC92 mRNA | CTD | PMID:36041667 | Ccdc92 | Rat | Brodifacoum | decreases expression | EXP | | 6480464 | bromfenacoum results in decreased expression of CCDC92 protein | CTD | PMID:28903499 | Ccdc92 | Rat | cadmium atom | multiple interactions | ISO | CCDC92 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CCDC92 mRNA | CTD | PMID:35301059 | Ccdc92 | Rat | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of CCDC92 mRNA | CTD | PMID:33453195 | Ccdc92 | Rat | cadmium dichloride | multiple interactions | ISO | CCDC92 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CCDC92 mRNA | CTD | PMID:35301059 | Ccdc92 | Rat | carbon nanotube | decreases expression | ISO | Ccdc92 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | Ccdc92 | Rat | CGP 52608 | multiple interactions | ISO | CCDC92 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CCDC92 gene] | CTD | PMID:28238834 | Ccdc92 | Rat | choline | multiple interactions | ISO | Ccdc92 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CCDC92 mRNA | CTD | PMID:20938992 | Ccdc92 | Rat | copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of CCDC92 mRNA | CTD | PMID:26033743 | Ccdc92 | Rat | copper atom | multiple interactions | ISO | CCDC92 (Homo sapiens) | 6480464 | [Disulfiram binds to Copper] which results in increased expression of CCDC92 mRNA | CTD | PMID:24690739 | Ccdc92 | Rat | copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of CCDC92 mRNA | CTD | PMID:26033743 | Ccdc92 | Rat | copper(0) | multiple interactions | ISO | CCDC92 (Homo sapiens) | 6480464 | [Disulfiram binds to Copper] which results in increased expression of CCDC92 mRNA | CTD | PMID:24690739 | Ccdc92 | Rat | copper(II) sulfate | decreases expression | ISO | CCDC92 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of CCDC92 mRNA | CTD | PMID:19549813 | Ccdc92 | Rat | cyclosporin A | decreases expression | ISO | CCDC92 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of CCDC92 mRNA | CTD | PMID:25562108 | Ccdc92 | Rat | DDE | decreases expression | ISO | CCDC92 (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of CCDC92 mRNA | CTD | PMID:38568856 | Ccdc92 | Rat | diarsenic trioxide | multiple interactions | ISO | CCDC92 (Homo sapiens) | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CCDC92 protein] | CTD | PMID:26598702 | Ccdc92 | Rat | Dibutyl phosphate | affects expression | ISO | CCDC92 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of CCDC92 mRNA | CTD | PMID:37042841 | Ccdc92 | Rat | dicrotophos | increases expression | ISO | CCDC92 (Homo sapiens) | 6480464 | dicrotophos results in increased expression of CCDC92 mRNA | CTD | PMID:28302478 | Ccdc92 | Rat | disulfiram | multiple interactions | ISO | CCDC92 (Homo sapiens) | 6480464 | [Disulfiram binds to Copper] which results in increased expression of CCDC92 mRNA | CTD | PMID:24690739 | Ccdc92 | Rat | dorsomorphin | multiple interactions | ISO | CCDC92 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCDC92 mRNA | CTD | PMID:27188386 | Ccdc92 | Rat | doxorubicin | decreases expression | ISO | CCDC92 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of CCDC92 mRNA | CTD | PMID:29803840 | Ccdc92 | Rat | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of CCDC92 mRNA | CTD | PMID:29391264 | Ccdc92 | Rat | entinostat | multiple interactions | ISO | CCDC92 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCDC92 mRNA | CTD | PMID:27188386 | Ccdc92 | Rat | entinostat | increases expression | ISO | CCDC92 (Homo sapiens) | 6480464 | entinostat results in increased expression of CCDC92 mRNA | CTD | PMID:27188386 | Ccdc92 | Rat | entinostat | decreases expression | ISO | CCDC92 (Homo sapiens) | 6480464 | entinostat results in decreased expression of CCDC92 mRNA | CTD | PMID:26272509 | Ccdc92 | Rat | ethanol | multiple interactions | ISO | Ccdc92 (Mus musculus) | 6480464 | Ethanol affects the expression of and affects the splicing of CCDC92 mRNA | CTD | PMID:30319688 | Ccdc92 | Rat | ethyl methanesulfonate | increases expression | ISO | CCDC92 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of CCDC92 mRNA | CTD | PMID:23649840 | Ccdc92 | Rat | folic acid | multiple interactions | ISO | Ccdc92 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CCDC92 mRNA | CTD | PMID:20938992 | Ccdc92 | Rat | formaldehyde | increases expression | ISO | CCDC92 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of CCDC92 mRNA | CTD | PMID:23649840 | Ccdc92 | Rat | furan | increases expression | EXP | | 6480464 | furan results in increased expression of CCDC92 mRNA | CTD | PMID:25539665 | Ccdc92 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of CCDC92 mRNA | CTD | PMID:33387578 | Ccdc92 | Rat | isobutanol | multiple interactions | ISO | CCDC92 (Homo sapiens) | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CCDC92 mRNA | CTD | PMID:29432896 | Ccdc92 | Rat | L-methionine | multiple interactions | ISO | Ccdc92 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CCDC92 mRNA | CTD | PMID:20938992 | Ccdc92 | Rat | maneb | multiple interactions | ISO | Ccdc92 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of CCDC92 mRNA | CTD | PMID:36117858 | Ccdc92 | Rat | methapyrilene | decreases methylation | ISO | CCDC92 (Homo sapiens) | 6480464 | Methapyrilene results in decreased methylation of CCDC92 intron | CTD | PMID:30157460 | Ccdc92 | Rat | methyl methanesulfonate | increases expression | ISO | CCDC92 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of CCDC92 mRNA | CTD | PMID:23649840 | Ccdc92 | Rat | N-methyl-4-phenylpyridinium | increases expression | ISO | CCDC92 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of CCDC92 mRNA | CTD | PMID:24810058 | Ccdc92 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of CCDC92 mRNA | CTD | PMID:25729387 | Ccdc92 | Rat | paracetamol | increases expression | ISO | CCDC92 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of CCDC92 mRNA | CTD | PMID:29067470 | Ccdc92 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CCDC92 mRNA | CTD | PMID:30723492 | Ccdc92 | Rat | paraquat | multiple interactions | ISO | Ccdc92 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of CCDC92 mRNA | CTD | PMID:36117858 | Ccdc92 | Rat | PCB138 | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:23829299 | Ccdc92 | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CCDC92 mRNA | CTD | PMID:35163327 | Ccdc92 | Rat | pirinixic acid | multiple interactions | ISO | CCDC92 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CCDC92 mRNA | CTD | PMID:19710929 | Ccdc92 | Rat | quercetin | increases expression | ISO | CCDC92 (Homo sapiens) | 6480464 | Quercetin results in increased expression of CCDC92 mRNA | CTD | PMID:21632981 | Ccdc92 | Rat | resveratrol | multiple interactions | ISO | CCDC92 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of CCDC92 mRNA | CTD | PMID:23557933 | Ccdc92 | Rat | SB 431542 | multiple interactions | ISO | CCDC92 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCDC92 mRNA | CTD | PMID:27188386 | Ccdc92 | Rat | silver atom | increases expression | ISO | Ccdc92 (Mus musculus) | 6480464 | Silver results in increased expression of CCDC92 mRNA | CTD | PMID:27131904 | Ccdc92 | Rat | silver(0) | increases expression | ISO | Ccdc92 (Mus musculus) | 6480464 | Silver results in increased expression of CCDC92 mRNA | CTD | PMID:27131904 | Ccdc92 | Rat | sodium arsenite | decreases expression | ISO | CCDC92 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of CCDC92 mRNA | CTD | PMID:34032870 | Ccdc92 | Rat | sunitinib | increases expression | ISO | CCDC92 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of CCDC92 mRNA | CTD | PMID:31533062 | Ccdc92 | Rat | testosterone | decreases expression | ISO | Ccdc92 (Mus musculus) | 6480464 | Testosterone deficiency results in decreased expression of CCDC92 mRNA | CTD | PMID:33848595 | Ccdc92 | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CCDC92 mRNA] | CTD | PMID:31150632 | Ccdc92 | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CCDC92 mRNA | CTD | PMID:30723492 and PMID:31150632 | Ccdc92 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of CCDC92 mRNA | CTD | PMID:23411599 and PMID:34492290 | Ccdc92 | Rat | titanium dioxide | increases methylation | ISO | Ccdc92 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of CCDC92 gene | CTD | PMID:35295148 | Ccdc92 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of CCDC92 mRNA | CTD | PMID:25729387 | Ccdc92 | Rat | triphenyl phosphate | affects expression | ISO | CCDC92 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of CCDC92 mRNA | CTD | PMID:37042841 | Ccdc92 | Rat | triptonide | increases expression | ISO | Ccdc92 (Mus musculus) | 6480464 | triptonide results in increased expression of CCDC92 mRNA | CTD | PMID:33045310 | Ccdc92 | Rat | urethane | increases expression | ISO | CCDC92 (Homo sapiens) | 6480464 | Urethane results in increased expression of CCDC92 mRNA | CTD | PMID:28818685 | Ccdc92 | Rat | valproic acid | increases expression | ISO | CCDC92 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of CCDC92 mRNA | CTD | PMID:23179753 and PMID:28001369 | Ccdc92 | Rat | valproic acid | increases methylation | ISO | CCDC92 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of CCDC92 gene | CTD | PMID:29154799 | Ccdc92 | Rat | valproic acid | affects expression | ISO | CCDC92 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CCDC92 mRNA | CTD | PMID:25979313 | Ccdc92 | Rat | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of CCDC92 mRNA | CTD | PMID:23034163 | |